These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23611264)

  • 1. [Improvement in pathological diagnosis for targeted therapy towards standardization].
    Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2013 Jan; 42(1):1-3. PubMed ID: 23611264
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of access to targeted cancer therapy.
    Burki TK
    Lancet Oncol; 2015 Oct; 16(13):e482. PubMed ID: 26321211
    [No Abstract]   [Full Text] [Related]  

  • 3. How Imaging Biomarkers Can Inform Clinical Trials and Clinical Practice in the Era of Targeted Cancer Therapy.
    Farwell MD; Clark AS; Mankoff DA
    JAMA Oncol; 2015 Jul; 1(4):421-2. PubMed ID: 26181243
    [No Abstract]   [Full Text] [Related]  

  • 4. Using Somatic Mutations to Guide Treatment Decisions: Context Matters.
    Horlings HM; Shah SP; Huntsman DG
    JAMA Oncol; 2015 Jun; 1(3):275-6. PubMed ID: 26181166
    [No Abstract]   [Full Text] [Related]  

  • 5. JAMA Oncology Patient Page. The Evolution of a Cancer.
    West HJ; Jin JO
    JAMA Oncol; 2015 Sep; 1(6):850. PubMed ID: 26247697
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.
    Le Tourneau C; Delord JP; Gonçalves A; Gavoille C; Dubot C; Isambert N; Campone M; Trédan O; Massiani MA; Mauborgne C; Armanet S; Servant N; Bièche I; Bernard V; Gentien D; Jezequel P; Attignon V; Boyault S; Vincent-Salomon A; Servois V; Sablin MP; Kamal M; Paoletti X;
    Lancet Oncol; 2015 Oct; 16(13):1324-34. PubMed ID: 26342236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prospective Incorporation of Molecular Profiling Will Transform Global Cancer Care.
    Marshall JL
    Oncology (Williston Park); 2020 Sep; 34(9):356-357. PubMed ID: 32965666
    [No Abstract]   [Full Text] [Related]  

  • 8. Next-Generation Sequencing in Oncology in the Era of Precision Medicine.
    Blumenthal GM; Mansfield E; Pazdur R
    JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticipating designer drug-resistant cancer cells.
    Frangione ML; Lockhart JH; Morton DT; Pava LM; Blanck G
    Drug Discov Today; 2015 Jul; 20(7):790-3. PubMed ID: 25697478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selected Articles from This Issue.
    Clin Cancer Res; 2020 May; 26(10):2279. PubMed ID: 32414759
    [No Abstract]   [Full Text] [Related]  

  • 11. Undruggable KRAS-time to rebrand?
    The Lancet Oncology
    Lancet Oncol; 2021 Mar; 22(3):289. PubMed ID: 33662279
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of Chromosomal Abnormalities with Different In Situ Hybridisation Techniques--the Usefulness in the Qualification of Cancer Patients for Molecularly-Targeted Therapies.
    Nicoś M; Wojas-Krawczyk K; Krawczyk P; Milanowski J
    Adv Clin Exp Med; 2015; 24(4):715-23. PubMed ID: 26469118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized-medicine trials on the rise.
    Benowitz S
    J Natl Cancer Inst; 2012 Oct; 104(19):1425-6. PubMed ID: 23008496
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers.
    Singh N; Krishnakumar S; Kanwar RK; Cheung CH; Kanwar JR
    Drug Discov Today; 2015 May; 20(5):578-87. PubMed ID: 25433305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selected Articles from This Issue.
    Clin Cancer Res; 2020 Apr; 26(8):1779. PubMed ID: 32295813
    [No Abstract]   [Full Text] [Related]  

  • 16. RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy.
    Indovina P; Pentimalli F; Casini N; Vocca I; Giordano A
    Oncotarget; 2015 Jul; 6(20):17873-90. PubMed ID: 26160835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial.
    Takata M
    Mutat Res; 2017 Oct; 803-805():42. PubMed ID: 28625404
    [No Abstract]   [Full Text] [Related]  

  • 18. Selected Articles from This Issue.
    Mol Cancer Ther; 2020 Jul; 19(7):1383. PubMed ID: 32616655
    [No Abstract]   [Full Text] [Related]  

  • 19. PD-L1 Testing in Cancer: Challenges in Companion Diagnostic Development.
    Hansen AR; Siu LL
    JAMA Oncol; 2016 Jan; 2(1):15-6. PubMed ID: 26562503
    [No Abstract]   [Full Text] [Related]  

  • 20. Foreword.
    Wells S
    Recent Results Cancer Res; 2015; 204():v-vi. PubMed ID: 26714327
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.